Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. - Wikidata - wikimedia - TriplyDB

Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis.

Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis.

http://www.wikidata.org/entity/Q33952717

about

Mechanisms of ectopic calcification: implications for diabetic vasculopathy Arterial calcification in chronic kidney disease: key roles for calcium and phosphate Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells.A current understanding of vascular calcification in CKD.The molecular biology and pathophysiology of vascular calcification.Vascular calcification is coupled with phenotypic conversion of vascular smooth muscle cells through Klf5-mediated transactivation of the Runx2 promoter.Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD).Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease.Inhibition of bone morphogenetic protein signal transduction prevents the medial vascular calcification associated with matrix Gla protein deficiency.Wnt16 attenuates TGFβ-induced chondrogenic transformation in vascular smooth muscle.Npp1 promotes atherosclerosis in ApoE knockout mice Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification.Characterization of Pax3-expressing cells from adult blood vessels.Runx2 Expression in Smooth Muscle Cells Is Required for Arterial Medial Calcification in Mice.Arterial calcification and bone physiology: role of the bone-vascular axis.SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation.Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification.MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification.Endogenous Sulfur Dioxide Inhibits Vascular Calcification in Association with the TGF-β/Smad Signaling Pathway.MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms.Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation.Ethanol increases phosphate-mediated mineralization and osteoblastic transformation of vascular smooth muscle cells.Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin Inducible expression of Runx2 results in multiorgan abnormalities in mice.Vitamin D and vascular calcification in chronic kidney disease.The realm of vitamin K dependent proteins: shifting from coagulation toward calcification.Vascular Calcification in Uremia: New-Age Concepts about an Old-Age Problem.Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification.CDKN2A/p16INK4a expression is associated with vascular progeria in chronic kidney disease.Scaffold-Free Fabrication of Osteoinductive Cellular Constructs Using Mouse Gingiva-Derived Induced Pluripotent Stem Cells.Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.Lanthanum carbonate prevents accelerated medial calcification in uremic rats: role of osteoclast-like activity.Kruppel-like factor 4 contributes to high phosphate-induced phenotypic switching of vascular smooth muscle cells into osteogenic cells.miRNA-221 and miRNA-222 synergistically function to promote vascular calcification.Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification.Runx2 Deletion in Smooth muscle Cells Inhibits Vascular Osteochondrogenesis and Calcification but not Atherosclerotic Lesion Formation.Methylation and expression of RECK, P53 and RUNX genes in patients with esophageal cancer.

P2860

Q26778664-5873056A-8512-4984-B6FA-5E73951AECCC Q26827655-A7DCAF23-5268-4FFE-AD3A-550944CCF353 Q30318113-D2D4684C-4B81-4D79-8715-4E3E416FB26A Q33700483-0DBBEAB8-3C82-4280-B3B7-974678AFBB16 Q34355897-59B57439-3B02-475B-B24C-8A70DF17F5E9 Q34412941-A122B3B9-9633-4F75-858A-4518D420427D Q34448785-BB2B83EB-FA32-4C86-8DD7-D72ABFA7CF94 Q34746039-50BC27F0-FB11-4C94-961E-CE89FE3F0E44 Q34755816-3B40A70E-F0E8-4DF5-9792-9FD4F6DBF251 Q34989385-6A592530-93EC-4090-9D51-6109D4FF3A3D Q35130798-EB033511-59C4-41DA-B2AF-EF172D224FCA Q35161110-604E41E4-02E4-4887-B3A1-44C7158049EF Q35525230-A28EE16C-A04F-4C9E-B538-EBE69A422FC3 Q35630647-F048279B-5158-40F2-9DBF-D4DD93C433B7 Q35792795-7ADD33D2-EBA9-4D61-93EF-3F72498B6452 Q36177303-63430055-8F23-4D24-B267-ADF257813BD5 Q36253058-6B9F8E41-1F23-48BB-961D-5BA89FC6594F Q36309309-61BEEAA9-F9BA-4342-8E3F-AB62520CD473 Q36314694-0D1EAA02-E580-439B-82DB-F8B58A36CEE3 Q36743432-9F07E306-CE59-4FED-8EEE-7DCA3D45E9B6 Q36890424-4EA8A94A-22DE-4700-BAFA-094B0A0140D4 Q36905955-71B9FC2A-9AA6-4CE2-9EB0-2ED6DD1B0AF1 Q36917940-DBC2CB22-F35E-4EE3-B24C-05DB445CEDAE Q37053665-608F3F2F-78EE-46F2-9C42-CC27C4C000D0 Q37294947-4AB05744-51D8-4696-B569-A1090EA22306 Q37312267-2F10CCC7-DB6D-4FE5-A9A2-B76603B7DFA9 Q37365273-F92CC144-82ED-4DA8-BF7B-084842468D90 Q37892311-2D32DA33-A3DF-456F-8BCD-E49877FEF323 Q38199459-AF743BF7-2377-4EE1-A6F1-10081EB0F762 Q38671493-798DFF94-0CC0-47E9-BAA2-FF65411D3D61 Q38768448-4FBF49EB-F164-4253-B92E-59442F0D86DE Q38964182-524F2895-23CF-4601-8E83-E056219DD3F9 Q40008428-D91CF9CC-D929-4BE5-BD77-86B60808351C Q40719297-F5711553-5422-421E-A693-47675411719E Q41846974-D0C5CEED-0296-45B3-A6D4-6D442724C07F Q41855705-949C177E-23DD-47BC-87C9-70E3BA655640 Q42084206-DA3BD798-F38C-457F-8DA4-C87CA468A9C8 Q42114732-E0C592EF-405E-421A-A55E-7FAC793389E4 Q42717904-FB7479AF-70CA-4842-B263-E35240AB5E84 Q45731738-015BB9D0-1CC6-46A2-AF58-8EDC64D83111

P2860

Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis.

http://www.wikidata.org/entity/Q33952717

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Runx2/Cbfa1, but not loss of m ...... ng toward osteochondrogenesis.

@ast

Runx2/Cbfa1, but not loss of m ...... ng toward osteochondrogenesis.

@en

type

label

Runx2/Cbfa1, but not loss of m ...... ng toward osteochondrogenesis.

@ast

Runx2/Cbfa1, but not loss of m ...... ng toward osteochondrogenesis.

@en

prefLabel

Runx2/Cbfa1, but not loss of m ...... ng toward osteochondrogenesis.

@ast

Runx2/Cbfa1, but not loss of m ...... ng toward osteochondrogenesis.

@en

P1433

Q33952717-957857AF-270F-495A-AA44-45D8987814E6

P1476

Q33952717-D826D336-A58B-49E0-A744-218448EA6C61

P2093

Q33952717-528A86BB-73B7-4EA8-8291-2C81BF9BC9E6

Q33952717-71DFE6BA-41DB-4C16-B7CA-FBC444EF990A

Q33952717-79E4919D-EBEA-4EBC-AF26-886DEB46FC57

Q33952717-FF9CABE2-E86C-4E59-839B-B1B475B38292

P2860

Q33952717-0A30205F-5940-4D4D-94A1-09C5105E2137

Q33952717-1315E016-4860-4FD1-B18C-F2ED4A9DF423

Q33952717-282CF2D0-4239-412F-B8F6-A7DEF1A7B8AC

Q33952717-2C3BF503-4E64-4FB1-B369-EF97119662A8

Q33952717-2DA959DC-54F0-4B60-93C3-5BFEE536CBCF

Q33952717-2FF5735D-7643-4952-AE7F-B503183EACDE

Q33952717-31A7A68A-69A1-448C-95CD-5548806ACC6B

Q33952717-3A388552-CEF9-47BF-A535-AE94A8B94C46

Q33952717-3F5B7D93-FBCE-4F95-9EB1-4299CABD1552

Q33952717-4F65BAF0-7F35-4AB3-BB98-61013C975F01

P304

Q33952717-D340336B-C01D-4005-84DE-F46AE180CFE1

P31

Q33952717-39A8974E-8023-4DFF-B484-C79C856058CF

P356

Q33952717-5BF0B0A4-C91E-4CA2-A759-4477B49A7B23

P433

Q33952717-144CA190-8FD4-4BAC-8730-568114597A2A

P478

Q33952717-9A8FAF56-FC2E-424D-9D0B-E832FB94BCCA

P577

Q33952717-5B8FBBE4-2200-4B91-828D-D905BB25BCB5

P5875

Q33952717-7984A415-09A8-4BE6-8234-B6EA47283243

P698

Q33952717-AD314839-2378-49F4-B7BD-986A9F762368

P932

Q33952717-E125DE96-E531-4DC4-9028-4EAE90640755

P356

P1433

Journal of Cellular Biochemistry

P1476

Runx2/Cbfa1, but not loss of m ...... ng toward osteochondrogenesis.

@en

P2093

Cecilia M Giachelli

http://www.w3.org/2001/XMLSchema#string

Mei Y Speer

http://www.w3.org/2001/XMLSchema#string

Pranoti G Hiremath

http://www.w3.org/2001/XMLSchema#string

Xianwu Li

http://www.w3.org/2001/XMLSchema#string

P2860

Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation.

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

Phosphate regulation of vascular smooth muscle cell calcification

Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor

Bone morphogenetic protein-induced MSX1 and MSX2 inhibit myocardin-dependent smooth muscle gene transcription

The serum response factor coactivator myocardin is required for vascular smooth muscle development

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

Detection and quantification of cardiovascular calcifications with electron beam tomography to estimate risk in hemodialysis patients.

P304

935-947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.22607

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44688754

http://www.w3.org/2001/XMLSchema#string

P698

20564193

http://www.w3.org/2001/XMLSchema#string

P932

2895022

http://www.w3.org/2001/XMLSchema#string